Piramal Pharma Limited (PPLPHARMA) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Piramal Pharma Limited stock ₹121, price ₹245, that is 50.5% below the price, quality 36 out of 100. Rating: strongly overvalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Piramal Pharma Limited
PPLPHARMA · NSEFar too expensive (fair value 51% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
49‑month range ₹63.86 – ₹293.36 · fair‑value band ₹59.74 – ₹215.41 · the ₹244.93 price screens above the ₹121.34 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Piramal Pharma is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network.
Show moreShow less
It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence.
The company was incorporated in 2020 and is based in Mumbai, India.
Stock analysis
Piramal Pharma Limited (PPLPHARMA) currently trades at ₹244.93, while our model-based Fair Value estimate is ₹121.34, 51% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹74.04 per share, and 0 of the 9 models we run sit above the ₹244.93 price.
Bear case: the Asset-Based group reads lowest at ₹20.31, and 9 of the 9 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹59.74 (bear) to ₹215.41 (bull), the price of ₹244.93 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Piramal Pharma Limited reported revenue of ₹88.7B in FY2026 versus ₹64.7B in FY2022, a compound +8.2%/yr. Reported net income was −₹3.3B in FY2026.
Key figures
Market cap ₹325B (≈ $3.4B) Mid · P/S ratio 3.24 · EPS (TTM) ₹−1.58 · Dividend yield 0.1% · Net margin −2.1% · Return on equity −2.6% · Return on assets (EBIT) 2.1% (5-year average) · Operating margin 4.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (medium confidence).
What moves the price
The share trades about 1% below its 52-week high and 84% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −51%, PPLPHARMA screens richer than that median.
Fair Value models
All 9 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
PPLPHARMA screens overvalued: fair value 51% below the price. Compare with Merck KGaA →
Compare Piramal Pharma Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Revenue growth by industry
- PEG ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs PPLPHARMA |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs PPLPHARMA |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs PPLPHARMA |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs PPLPHARMA |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs PPLPHARMA |
| Galderma Group GALD | CHF 191.00 | CHF 112.30 | −41% | vs PPLPHARMA |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs PPLPHARMA |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs PPLPHARMA |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs PPLPHARMA |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs PPLPHARMA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Piramal Pharma Limited (PPLPHARMA) overvalued or undervalued?
What is the fair value of PPLPHARMA?
What is the quality score of PPLPHARMA?
What is the price target for Piramal Pharma Limited (PPLPHARMA)?
What is the Piramal Pharma Limited stock forecast for 2026?
What is the revenue of Piramal Pharma Limited (PPLPHARMA)?
Does Piramal Pharma Limited pay a dividend?
How much is the dividend of Piramal Pharma Limited (PPLPHARMA)?
What growth is priced into Piramal Pharma Limited (PPLPHARMA)?
What discount rate (WACC) does the fair value of PPLPHARMA use?
What is a reverse DCF?
How much growth has Piramal Pharma Limited (PPLPHARMA) delivered so far?
How fast is the sector of Piramal Pharma Limited (PPLPHARMA) growing?
What is the free cash flow yield of Piramal Pharma Limited (PPLPHARMA)?
What is the intrinsic value of Piramal Pharma Limited (PPLPHARMA)?
Is Piramal Pharma Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of PPLPHARMA?
How much is Piramal Pharma Limited worth?
What do the bullish and bearish scenarios say about PPLPHARMA?
How solid is the balance sheet of Piramal Pharma Limited (PPLPHARMA)?
How far is PPLPHARMA from its 52-week high?
Which stocks are comparable to Piramal Pharma Limited?
Is Piramal Pharma Limited stock attractive at the current price?
How is the fair value of PPLPHARMA calculated?
Is it still worth investing in stocks now?
What is the share price of Piramal Pharma Limited (PPLPHARMA)?
What should I pay attention to with Piramal Pharma Limited right now?
Key figures of Piramal Pharma Limited
How large is the market capitalisation of Piramal Pharma Limited (PPLPHARMA)?
What is the P/S ratio of Piramal Pharma Limited (PPLPHARMA)?
What are the earnings per share of Piramal Pharma Limited (PPLPHARMA)?
What is the dividend yield of Piramal Pharma Limited (PPLPHARMA)?
What is the net margin of Piramal Pharma Limited (PPLPHARMA)?
What is the return on equity of Piramal Pharma Limited (PPLPHARMA)?
What is the EBIT return on assets of Piramal Pharma Limited (PPLPHARMA)?
What is the operating margin of Piramal Pharma Limited (PPLPHARMA)?
How fast is revenue growing at Piramal Pharma Limited (PPLPHARMA)?
How fast are earnings growing at Piramal Pharma Limited (PPLPHARMA)?
How much net debt does Piramal Pharma Limited (PPLPHARMA) carry?
Watch Piramal Pharma Limited in the live analysis
One click puts Piramal Pharma Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.